1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Endophthalmitis Global Clinical Trials Review, H2, 2014

Endophthalmitis Global Clinical Trials Review, H2, 2014

  • November 2014
  • -
  • Global Data
  • -
  • 56 pages

Endophthalmitis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Endophthalmitis Global Clinical Trials Review, H2, 2014" provides data on the Endophthalmitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endophthalmitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Endophthalmitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Endophthalmitis Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 5
Endophthalmitis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Endophthalmitis to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Endophthalmitis to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Endophthalmitis 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Drugs 26
Clinical Trial Overview of Top Institutes / Government 27
Royal Berkshire NHS Foundation Trust 27
Clinical Trial Overview of Royal Berkshire NHS Foundation Trust 27
CHU Dijon 28
Clinical Trial Overview of CHU Dijon 28
Arak University of Medical Sciences 29
Clinical Trial Overview of Arak University of Medical Sciences 29
Erasmus MC 30
Clinical Trial Overview of Erasmus MC 30
Zhejiang University 31
Clinical Trial Overview of Zhejiang University 31
University of Chicago 32
Clinical Trial Overview of University of Chicago 32
National Eye Institute 33
Clinical Trial Overview of National Eye Institute 33
Queen's University 34
Clinical Trial Overview of Queen's University 34
Stanford University 35
Clinical Trial Overview of Stanford University 35
Vanderbilt University 36
Clinical Trial Overview of Vanderbilt University 36
Five Key Clinical Profiles 37
Appendix 54
Abbreviations 54
Definitions 54
Research Methodology 55
Secondary Research 55
About GlobalData 56
Contact Us 56
Disclaimer 56
Source 56

List of Tables

Endophthalmitis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Endophthalmitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Endophthalmitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Endophthalmitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Endophthalmitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Endophthalmitis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Endophthalmitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Endophthalmitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Endophthalmitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Endophthalmitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Endophthalmitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Endophthalmitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Endophthalmitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Endophthalmitis Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Endophthalmitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Endophthalmitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Endophthalmitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Endophthalmitis Therapeutics, Global, Suspended Clinical Trials, 2014* 23
Endophthalmitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Endophthalmitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Endophthalmitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Berkshire NHS Foundation Trust, 2014* 27
Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by CHU Dijon, 2014* 28
Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2014* 29
Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 30
Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zhejiang University, 2014* 31
Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2014* 32
Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014* 33
Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2014* 34
Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 35
Endophthalmitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 36

List of Figures

Endophthalmitis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Endophthalmitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Endophthalmitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Endophthalmitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Endophthalmitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Endophthalmitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Endophthalmitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 12
Proportion of Endophthalmitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Endophthalmitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Endophthalmitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Endophthalmitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Endophthalmitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Endophthalmitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Endophthalmitis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Endophthalmitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Endophthalmitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Endophthalmitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Endophthalmitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Endophthalmitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Endophthalmitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 55

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.